SMI Adviser Long-Acting Injectable Center of Excellence
Education, resources, and evidence-based answers to help you optimize the use of LAIsWelcome to the Long-Acting Injectable (LAI) Center of Excellence (COE)
SMI Adviser created the LAI COE to promote the safe and effective use of LAIs. The ultimate goal of this effort is to improve the lives of individuals who have schizophrenia, schizoaffective, and bipolar disorders. The LAI COE provides clinicians with training opportunities, technical assistance, and vetted resources. These include:
- Live and on-demand webinars
- Virtual Learning Collaboratives
- Virtual Forums
- Email listserv
- On-demand consultations
- Intensive consultation to sites or communities
- Clinical tips and resources
The LAI COE is led by SMI Nursing Expert, Donna Rolin, PhD, APRN, SMI Adviser Pharmacist Expert, Megan Ehret, PharmD, Robert Cotes, MD, SMI Adviser Physician Expert and SMI Adviser content partner, National Association of State Mental Health Program Directors (NASMHPD), and supported by members of the LAI Workgroup.
For individual and family resources on using long-acting injectables, visit the individual and family Knowledge Base.
LAI Injection Videos
SMI Adviser is proud to present this five-part video series on the proper preparation and
administration of LAI medications.
Video: Intramuscular (IM) Injection of Long-acting Injectables into Deltoid Site
This video demonstrates how to administer (a long-acting injectable) medication…
Video: Intramuscular (IM) Injection of Long-acting Injectables into Ventral Gluteal (or Ventrogluteal) Site
This video demonstrates how to administer (a long-acting injectable) medication…
Video: Intramuscular (IM) Injection of Long-acting Injectables into Dorsal Gluteal (or Dorsogluteal) Site
This video demonstrates how to administer (a long-acting injectable) medication…
Video: Subcutaneous (SC) Injection of Long-acting Injectables into Lateral Aspect of Upper Arm
This video demonstrates how to administer (a long-acting injectable) medication…
Video: Subcutaneous (SC) Injection of Long-acting Injectables into Abdominal Site
This video demonstrates how to administer (a long-acting injectable) medication…
Resources
Education
Join Us
Consultation
Resources on Long-Acting Injectables
Browse resources and find answers from the SMI Adviser Knowledge Base
Expanding Your Long-Acting Injectable (LAI) Antipsychotic Medication Toolbox
Updates in Proper Use and Administration of Long-Acting Injectable Antipsychotics
Psychiatric Medications in Pregnancy
Learning From Each Other: Reimagining the Role of Medication in Crisis Care
Worth a Shot? Evidence-Based Approach to Prescribing LAI Antipsychotic Medications
A Delicate Dance: The Principles and Practice of Deprescribing Antipsychotic Medications
Approaches to Conversations About Long-Acting Injectable Antipsychotics
Clinician’s Guide to Preparing and Administering Long-Acting Injectable Antipsychotics
Maximizing Treatment Success for Patients with SMI: Promoting Adherence and Treatment Engagement
Psychotropic Medications and Older Adults: Update on Safety Considerations
Clozapine & LAI Virtual Forum
Join us for a live peer-to-peer discussion each month to share your challenges and questions on trending topics around clozapine and LAIs. Sign up for the Clozapine and LAI Centers of Excellence Exchange above to receive invitations.
Get Expert Guidance on Questions Around LAIs
Submit any questions you have on managing side effects, assessment and monitoring, medical comorbidities, and any other topic. Receive a response within one business day from one of our national experts.
Trending Topics
Use our Knowledge Base to find evidence-based answers and resources on LAIs. Here are some new and popular topics — all vetted by our Clinical Expert Team.
What do APA’s Schizophrenia Treatment Guidelines say about long-acting injectable antipsychotics?
On September 1, 2020, the American Psychiatric Association released a…
What long-acting injectable (LAI) antipsychotic medications are available in the U.S.?
See clinical tips available (linked below) on individual LAIs for…
What should clinicians know about Perseris (risperidone subcutaneous LAI)?
Perseris is a long-acting injectable (LAI) formulation of risperidone. It…
What mistakes should providers be aware of when prescribing and administering long-acting injectables (LAIs)?
Mistakes in preparation:
Not all injections are given the…
How do I treat an acute dystonic reaction (ADR)?
ADRs are best avoided as this acute neurological side effect…
How are prolactin levels impacted by long-acting injectable (LAI) antipsychotic medications?
Hyperprolactinemia is often caused by the use of antipsychotic medications,…
What can be done if a LAI medication becomes less effective part way through the inter-injection interval?
There are several reasons why a LAI medication might have…
What are clinical considerations for giving LAIs during the COVID-19 public health emergency?
Since LAI antipsychotics need…
I am going to start a new long-acting injectable antipsychotic (LAI) medication soon. I’m worried about how much injections hurt when I get them in my arm, so are there other options about where to get the shot?
There are many different options of LAIs available. See this…
What is shared decision making and how does it apply to using long-acting injectables (LAIs)?
Shared Decision Making (SDM) is a collaborative process between a…